Insider Trading & Ownership - Schramm Vern Lee

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Schramm Vern Lee

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-03
Option Award
2022-01-03
9:06 pm
N/A
2032-01-03
First Wave BioPharma Inc.FWBISchramm Vern Lee
Director
34,482$034,482
(Direct)
View
2021-01-04
Option Award
2021-01-06
9:46 pm
N/A
2031-01-03
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
41,237$041,237
(Direct)
View
2020-04-06
Option Award
2020-04-07
7:52 pm
N/A
2030-04-06
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
80,000$080,000
(Direct)
View
2020-03-11
Option Award
2020-03-13
4:10 pm
N/A
N/A
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
14,584$0.690,498
(Direct)
View
2020-03-11
Option Award
2020-03-13
4:10 pm
N/A
N/A
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
8,414$1.0490,498
(Direct)
View
2019-12-31
Option Award
2020-01-03
4:06 pm
N/A
N/A
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
7,500$1.0467,500
(Direct)
View
2019-09-30
Option Award
2019-10-01
2:25 pm
N/A
N/A
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
7,500$0.660,000
(Direct)
View
2019-06-30
Option Award
2019-07-02
6:37 pm
N/A
N/A
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
7,500$1.752,500
(Direct)
View
2019-06-13
Option Award(A)
2019-06-21
8:04 pm
N/A
2024-06-13
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
30,000$030,000
(Direct)
View
2019-06-13
Option Award
2019-06-17
9:48 pm
N/A
N/A
AzurRx BioPharma Inc.AZRXSchramm Vern Lee
Director
30,000$075,000
(Direct)
View
(A) Indicate amendment filing.